Seelos Therapeutics Ord shares owned by UBS Group
Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Seelos Therapeutics Ord
Tip: Access up to 7 years of quarterly data
All positions including Seelos Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Seelos Therapeutics Ord by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $6.0k | 10k | 0.59 |
2023-12-31 | $407 | 407 | 1.00 |